COMPNAY REPORTS - ChangeWave

2004-12-08 · Biotech Research Funding in 2005. Respondents rank Anti-Angiogenesis (15%) and Gene Therapy (15%) as the biotech research areas that will attract the most private and public funding in 2005. Monoclonal Antibody (12%) and Proteomics (12%) also received double digit mention. Companies with Best Prospects of Success in RNA Interference Drug Trials. Fourteen percent (14%) of respondents … ................
................